Noninvasive brain stimulation to see if it lowers pain in fibromyalgia
Official title: Transcranial Electrical Stimulation for Noninvasive Study of Pain Circuits in Patients With Chronic Pain
Run by Carnegie Mellon University · NCT07644221 · Data updated 2026-11-12
This study tests whether daily noninvasive brain stimulation can reduce pain and improve quality of life for people with fibromyalgia, using two brain targets and a crossover design.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Carnegie Mellon University Academic / other |
| Locations | 2 sites (Pittsburgh, Pennsylvania and 1 other locations) |
| Status | Recruiting |
| Started | September 9, 2026 |
| Main results expected | December 2027 |
| Study ends | May 2028 |
| Registry record updated | October 21, 2026 |
| Trial ID | NCT07644221 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with fibromyalgia who have persistent pain despite standard pain medications and meet safety criteria.
✕Probably not a fit
Those without improvement in pain or quality-of-life measures or with safety exclusions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study explores whether noninvasive brain stimulation (NIBS) can alter pain perception in fibromyalgia. Participants receive daily NIBS sessions over four weeks, with pain testing and quality-of-life questionnaires. In a randomized crossover design, they receive stimulation to the primary motor cortex and to the occipital lobe in different periods, separated by a washout. Each session includes pressure pain measurements and up to five hours of assessments to track symptom changes and well-being. The study uses brief electrical pulses to stimulate targeted brain regions and compares effects between brain targets.
Why it matters
Potential benefit: If successful, participants with fibromyalgia may experience reduced pain and improved quality of life from NIBS.
How similar studies have gone: Previous research with similar noninvasive brain stimulation approaches has shown mixed but promising results in chronic pain conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Formal diagnosis of fibromyalgia made by a practicing physician * Pain resistant to common analgesics and medications for chronic pain * Existing pain for more than 3 months with an average of at least 4 on a 0 to 10 Numerical Rating Scale (NRS) * Females of child bearing potential must be at least one of the following totally abstinent from heterosexual intercourse since the last menses before start of study, or agree to concurrent use of at least two methods of birth control throughout study participation. Exclusion Criteria: * If the subject is non-ambulatory. * If the subject is female of child-bearing potential, subject must not be pregnant. * Subject must not have a history of brain surgery or uncontrolled neurological conditions, such as seizure, fainting spells, transient ischemic attack. * Subject must not have lifetime history of severe, uncontrolled mood disorders (anxiety, depression, bipolar), psychotic disorders, other neural disorders, or heart disease. * Subject must not have any implanted electronic or metallic devices. * Subject must not have heart diseases, including known arrhythmia, or severe liver or severe gastrointestinal disease or chronic severe infectious disease (e.g. HIV/AIDS).
Where it's running
-
UPMC Pain Management
Pittsburgh, Pennsylvania, United States Recruiting -
Carnegie Mellon University
Pittsburgh, Pennsylvania, United States Not yet recruiting
Study contacts
- Principal investigator: Pulkit Grover, PhD — Carnegie Mellon University
- Study coordinator: Pulkit Grover, PhD
- Email: pgrover@andrew.cmu.edu
- Phone: 412-268-3644
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID
This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.
-
Home-based high-dose tDCS for fibromyalgia: predicting response and comparing brain targets
This study tests whether a high-dose home-based tDCS treatment is at least as good as the conventional home-based tDCS for people with fibromyalgia, and whether it could be better, while also checking if baseline EEG can predict who responds.
-
Dietary strategies to help fibromyalgia in overweight or obese women
This trial tests whether a very low-calorie ketogenic diet, a Mediterranean diet, or a Mediterranean diet with a probiotic can reduce fibromyalgia symptoms in overweight or obese women.
-
Isokinetic microdose exercise for women with fibromyalgia
This 8-week program will test whether low-dose isokinetic exercise helps women with fibromyalgia reduce pain, improve strength, and enhance quality of life.
-
Does hardaliye help fibromyalgia when added to a personalized diet?
This study tests whether a traditional grape-based drink called hardaliye, used with a personalized diet, can improve symptoms and inflammation in adult women with fibromyalgia.
-
Personalized ultrasonic brain stimulation to reduce fibromyalgia symptoms
This study will test whether personalized low-intensity ultrasound to the brain can reduce pain and other symptoms in adults with fibromyalgia who have not improved after standard medications and physical therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.